M&A Deal Summary

Ampersand Capital Partners Acquires Leinco

On November 17, 2021, growth capital firm Ampersand Capital Partners acquired life science company Leinco

Acquisition Highlights
  • This is Ampersand Capital Partners’ 30th transaction in the Life Science sector.
  • This is Ampersand Capital Partners’ 56th transaction in the United States.
  • This is Ampersand Capital Partners’ 4th transaction in Missouri.

M&A Deal Summary
Date 2021-11-17
Target Leinco
Sector Life Science
Buyer(s) Ampersand Capital Partners
Deal Type Recapitalization

Target

Leinco

St. Louis, Missouri, United States
Leinco is a biotechnology company that is engaged in manufacturing of early discovery research products including antibodies, recombinant proteins, ELISA kits, second step reagents, and other life sciences products. Leinco was founded in 1992 and is based in St. Louis, Missouri.

Search 201,771 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 64 of 84
Sector (Life Science) 30 of 43
Type (Recapitalization) 4 of 7
State (Missouri) 4 of 4
Country (United States) 56 of 69
Year (2021) 8 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-15 Adaptas Solutions

Palmer, Massachusetts, United States

Adaptas Solutions is a strategic OEM supplier for key products and manufacturing services for analytical and laboratory equipment manufacturers. Adaptas’ manufacturing vertical integration strategy allows for rapid to-market product development and best in class costing while delivering high-quality products and services. Adaptas Solutions was established in 1983 and is based in Palmer, Massachusetts.

Sell $271M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-18 Resolian

Malvern, Pennsylvania, United States

Resolian is a contract research organization (CRO) that specializes in advanced bioanalytical research services for both small and large molecule drugs, as well as drug metabolism studies to support pharmaceutical and biotechnology companies’ drug discovery and development programs. Resolian was founded in 2008 and is headquartered in Malvern, Pennsylvania.

Buy -
Mergr

Product

Company

Legal